The Comparison of Outcomes between Video-assisted Thoracscopic and Open Surgery for Esophageal Cancer

Background: Minimally invasive esophagectomy theoretically has advantages over open esophagectomy. The purpose of the present study was to compare the short- and long-term outcomes of patients who underwent video-assisted thoracoscopic esophagectomy (VATE) or conventional open esophagectomy (OE) for...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Annals of Cancer Research and Therapy 2020/07/09, Vol.28(2), pp.97-101
Hauptverfasser: Tamagawa, Hiroshi, Numata, Masakatsu, Aoyama, Toru, Tamagawa, Ayako, Komori, Keisuke, Maezawa, Yukio, Kano, Kazuki, Kazama, Keisuke, Murakawa, Masaaki, Atsumi, Yosuke, Hara, Kentaro, Kawahara, Shinnosuke, Yamada, Takanobu, Ogata, Takashi, Ohshima, Takashi, Yukawa, Norio, Masuda, Munetaka, Rino, Yasushi
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background: Minimally invasive esophagectomy theoretically has advantages over open esophagectomy. The purpose of the present study was to compare the short- and long-term outcomes of patients who underwent video-assisted thoracoscopic esophagectomy (VATE) or conventional open esophagectomy (OE) for esophageal carcinoma.Methods: A total of 122 patients who underwent radical esophagectomy via VATE (VATE group, N = 87) and OE (OE group, N = 35) for esophageal carcinoma between 2005 and 2018 were retrospectively enrolled in this study, and the postoperative outcomes were compared.Results: The OE group had younger patients and more patients who received neo-adjuvant therapy that the VATE group. The procedure time in the OE group was also shorter than that in the VATE group (8.22 vs. 10.28 h, P < 0.001). Intraoperative blood loss was similar between the groups (P = 0.775). There were no significant differences in the total number of dissected lymph nodes between the groups (OE: 33, VATE: 37, P = 0.482). The incidence of severe complications was lower in the VATE group than in the OE group (44.8% vs. 65.7%, P = 0.037). With a median follow-up of 26 months, the 3-year overall survival and disease-free survival were similar between the two groups.Conclusion: VATE for esophageal carcinoma is associated with more favorable short-term outcomes and equal oncological outcomes compared with OE.
ISSN:1344-6835
1880-5469
DOI:10.4993/acrt.28.97